Results 251 to 260 of about 2,864,300 (339)

Glycemic therapies and the risk of gastrointestinal adverse events in veterans with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To compare the risk of gastrointestinal adverse events in new users of glucagon‐like peptide‐1 receptor agonists (GLP‐1RA), sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) and insulin glargine. Materials and Methods We conducted an active comparator, new user design study in veterans with type 2 diabetes who initiated one of these drug
Amara Sarwal, Ravinder Singh, Guo Wei, Jincheng Shen, McKenna Nevers, Sydney E. Hartsell, Catherine G. Derington, Augustine Takyi, Akhil R. Chakravartula, Niharika Katkam, Robert E. Boucher, Stavros G. Drakos, Tom Greene, Srinivasan Beddhu   +13 more
wiley   +1 more source

Endoscopic Management of Recurrent Acute Pancreatitis. [PDF]

J Clin Med
Testoni PA, Testoni S.
europepmc   +1 more source

The Role of Peritoneal Lavage in Severe Acute Pancreatitis

, 1978
John H.C. Ranson, Frank C. Spencer
openalex   +2 more sources

Clinical practice guideline: management of acute pancreatitis.

Canadian journal of surgery. Journal canadien de chirurgie, 2016
J. Greenberg, J. Hsu, M. Bawazeer, J. Marshall, J. Friedrich, A. Nathens, N. Coburn, G. May, E. Pearsall, R. McLeod   +9 more
semanticscholar   +1 more source

Real‐world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity clinic

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Trials of the Glucagon‐like Peptide‐1 Receptor Agonists (GLP1RAs) found mean weight losses of 15%–21%, yet realworld dose titration and persistence remain suboptimal, limiting effectiveness. This study aims to determine real‐world titration, persistence and effectiveness of GLP1RAs in patients managed within a multidisciplinary obesity ...
Jason M. Samuels, Fei Ye, Rebecca Irlmeier, Heidi Silver, Gitanjali Srivastava, Matthew Spann   +5 more
wiley   +1 more source

Association between albumin infusion and sepsis risk of patients with acute pancreatitis. [PDF]

PLoS One
Zhou X, Jiang B, You N, Qian X, Han D, Sun W.   +5 more
europepmc   +1 more source

Acute Pancreatitis with Hyperlipemia

, 1973
John L. Cameron, David M. Capuzzi, George D. Zuidema, Simeón Margolis   +3 more
openalex   +2 more sources

Incretin system and glucagon secretion in patients with chronic pancreatitis

European Journal of Clinical Investigation, EarlyView.
Diabetes of the exocrine pancreas (DEP) showed unclear incretin and glucagon dynamics. This cross‐sectional study compared 32 patients with chronic pancreatitis (wCP) and 60 without (w/oCP). Subjects wCP had worse beta‐cell function and lower incretin effect.
Gea Ciccarelli, Gianfranco Di Giuseppe, Giulia Gliozzo, Laura Soldovieri, Giuseppe Quero, Enrico Celestino Nista, Michela Brunetti, Francesca Cinti, Sara Sofia De Lucia, Bolette Hartmann, Andrea Mari, Antonio Gasbarrini, Sergio Alfieri, Alfredo Pontecorvi, Jens Juul Holst, Andrea Giaccari, Teresa Mezza   +16 more
wiley   +1 more source

Status epilepticus in older adults: A critical review

Epilepsia, EarlyView.
Abstract Older adults (≥60 years of age) have the highest incidence of status epilepticus (SE) among adults and experience the highest morbidity and mortality. SE incidence increases with age in adulthood. A recent study from Austria estimated an incidence of 89.6/100 000 and 67.6/100 000 person‐years adjusted for age and sex in women and men aged >60 ...
Matthew R. Woodward, Michael J. Armahizer, Tina I. Wang, Neeraj Badjatia, Emily L. Johnson, Emily J. Gilmore   +5 more
wiley   +1 more source

Pain intensity and prognosis of acute pancreatitis in an international, prospective study. [PDF]

Br J Surg
Knoph CS, PAINAP Collaborative , Pandanaboyana S.   +2 more
europepmc   +1 more source